Clover Corporation Limited (ASX:CLV)

Market Cap	123.58M +85.0%
Revenue (ttm)	86.00M +38.3%
Net Income	7.02M +382.5%
EPS	0.04 +382.8%
Shares Out	167.00M
PE Ratio	17.62
Forward PE	14.51
Dividend	0.02 (2.78%)
Ex-Dividend Date	Oct 20, 2025

Volume	27,630
Average Volume	239,753
Open	0.7400
Previous Close	0.7400
Day's Range	0.7400 - 0.7600
52-Week Range	0.3370 - 0.8650
Beta	-0.04
RSI	41.50
Earnings Date	Mar 12, 2026

About Clover Corporation

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. Clover Corporation Limited was incorporated in 1988 and is headquarte...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1988
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CLV

Financial Performance

In fiscal year 2025, Clover Corporation's revenue was 86.00 million, an increase of 38.25% compared to the previous year's 62.21 million. Earnings were 7.02 million, an increase of 382.46%.